Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04686799 · ClinicalTrials.gov registry record · Phase 1

Doxycycline for Elbow Tendinopathy

A Phase 1 study of Lateral Epicondylitis and Lateral Epicondylitis, Unspecified Elbow, sponsored by Hospital for Special Surgery, New York.

Active
Registry status
Phase 1
Development phase
25
Enrollment target
1
Study location

NCT04686799 is a Phase 1 study of Lateral Epicondylitis and Lateral Epicondylitis, Unspecified Elbow that is active but no longer recruiting, run by Hospital for Special Surgery, New York. The registered enrollment target is 25 participants, below the 124-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04686799, a Phase 1 study of Lateral Epicondylitis and Lateral Epicondylitis, Unspecified Elbow, is active but no longer recruiting, sponsored by Hospital for Special Surgery, New York.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

To evaluate the feasibility of subantimicrobial -dose (SD) doxycycline to improve outcomes of nonsurgical management of elbow tendinopathy via matrix metalloproteinase (MMP) inhibition as well as evaluate if participants will be compliant to with prescribed medication and exercise treatment. Our working hypothesis is that patients with elbow tendinopathy will be receptive to treatment with SD-doxycycline and compliant with the prescribed treatment.

Conditions Studied

Lateral Epicondylitis Lateral Epicondylitis, Unspecified Elbow Lateral Epicondylitis, Left Elbow Lateral Epicondylitis, Right Elbow Lateral Epicondylitis (Tennis Elbow) Bilateral Medial Epicondylitis Medial Epicondylitis, Right Elbow Medial Epicondylitis, Left Elbow

Interventions

  • DRUG Doxycycline Hyclate 20 MG

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2020-12-03
Est. Completion 2026-01
Phase Phase 1

Sponsor

Hospital for Special Surgery, New York

194 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04686799

The ClinicalTrials.gov registry entry for NCT04686799 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 124-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (80% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Lateral Epicondylitis appearing as the primary indexed condition, and to 1 intervention - of which Doxycycline Hyclate 20 MG is the first listed.

NCT04686799 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04686799 about?

NCT04686799 is a clinical study titled "Doxycycline for Elbow Tendinopathy". To evaluate the feasibility of subantimicrobial -dose (SD) doxycycline to improve outcomes of nonsurgical management of elbow tendinopathy via matrix metalloproteinase (MMP) inhibition as well as evaluate if participants will be compliant to with prescribed medication and exercise treatment. Our wor...

What is the current status of trial NCT04686799?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2020-12-03. Estimated completion is 2026-01.

What conditions does trial NCT04686799 study?

This clinical trial studies the following conditions: Lateral Epicondylitis, Lateral Epicondylitis, Unspecified Elbow, Lateral Epicondylitis, Left Elbow, Lateral Epicondylitis, Right Elbow, Lateral Epicondylitis (Tennis Elbow) Bilateral.

What interventions are being tested in trial NCT04686799?

The interventions under investigation include: Doxycycline Hyclate 20 MG (DRUG).

Who is sponsoring clinical trial NCT04686799?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04686799 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lateral Epicondylitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lateral Epicondylitis

All registered trials for this condition

Lateral Epicondylitis, Unspecified Elbow

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.